维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Colgan JP"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Testicular lymphoma is associated with a high incidence of extranodal recurrence显示文摘	Fonseca R Habermann TM Colgan JP	2000	Cancer2000，88，1：	1
2	Peripheral blood lymphocyte/monocyte ratio at diagnosis and sur- vival in classical Hodgkin' s lymphoma显示文摘	Porrata LF Ristow K Colgan JP	2012	Haemato- logica2012，97，2：	1
3	A Phase Ⅱ trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma 显示文摘	Johnston PB Inwards D J Colgan JP	2010	Am J Hematol2010，85，5：	1
4	Peripheral blood lymphocyte/ monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma显示文摘	Porrata LF Ristow K Colgan JP	2012	Haematologica2012，97，2：	1
5	mTOR inhibitor mono- therapy is insufficient to suppress viremia and disease progression in Epstein-Barr Virus-driven lymphoproliferative disorders (EBV- LPD) 显示文摘	Holtan SG Porrata LF Colgan JP	2008	Am J nematol2008，83，8：	1
6	Effectiveness of second line salvage chemotherapy with ifosfamide,carbo-platin,and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum,cyto-sine arabinoside,and dexamethasone显示文摘	Simpson L Ansell SM Colgan JP		0，，07：	1
7	Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in ly- mphoblastic non-Hodgkin's lymphoma显示文摘	Colgan JP Andersen J Habermann TM	1994	Leuk Lymphoma1994，15，34：	1
8	Phase Ⅱ trial of the oral mTOR inhibitor everolimus(RAD001)for patients with relapsed or refractory lymphoma显示文摘	Johnston PB Ansell SM Colgan JP	2007	J Clin Oncol2007，25，：	1
9	A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma显示文摘	Johnston PB Inwards DJ Colgan JP	2010	Am J Hematol2010，85，5：	1
10	Testicular lym-phoma is associated with a high incidence of extranodal recurrence显示文摘	Fonseca R Habermann TM Colgan JP	2000	Cancer2000，88，1：	1
11	Testicular lymphoma is associated with a high incidence of extranodal recurrence显示文摘	Fonseca R Habermann TM Colgan JP	2000	Cancer2000，88，1：	1
12	Testicular lymphoma is associated with a high incidence of extranodal recurrence显示文摘	Habermann TM Colgan JP	2000	Cancer2000，88，1：	1
13	Peripheral blood lympho- cyte/monocyte ratio at diagnosis and survival in classical Hodgkin~ lymphoma 显示文摘	Porrata LF Ristow K Colgan JP	2012	Haematologica2012，97，2：	1
14	Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma显示文摘	Porrata LF Ristow K Colgan JP	2012	Haematologica2012，97，2：	1
15	Intravascular lymphoma:Poor outcomes may be improved with aggressive therapy显示文摘	Yasenchak CA Dogan A Colgan JP	2005	106:Abstract 9382005，106，：	1
16	A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma显示文摘	Johnston PB Inwards DJ Colgan JP	2010	Am J Hematol2010，85，5：	1
17	Testicular lymphoma is associated with a high incidence of extranodal recurrence 显示文摘	Fonseca R Habermann TM Colgan JP	2000	Cancer2000，88，1：	1
18	Testicular lymphoma is associated with a high incidence of extranodal recurrence 显示文摘	Fonseca R Habermann TM Colgan JP	2000	Cancer2000，88，1：	1
19	Testicular ly- mphoma is associated with a high incidence of extranodal recurrence显示文摘	Fonseca R Habermann TM Colgan JP	2000	Cancer2000，88，：	1
20	Mtor inhibitor for relapsed and refractory Hodgkin lymphoma:promising single agent activity with everolimus显示文摘	Johnston PB Ansell SM Colgan JP	2007	Blood2007，110，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示